HCW Biologics Company
HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.
Total Funding:
$18.1M
Headquarters:
United States
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Number Of Exists:
Series B
Technology:
Geroscience
Investor Type:
Company
Investors Number:
2
Founded Date:
2018-04-01
Industry:
Others